{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:10:14Z","timestamp":1785186614906,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T00:00:00Z","timestamp":1307059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00216-011-5066-4","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T06:35:25Z","timestamp":1307082925000},"page":"599-607","source":"Crossref","is-referenced-by-count":27,"title":["Cannabinoids and metabolites in expectorated oral fluid after 8\u00a0days of controlled around-the-clock oral THC administration"],"prefix":"10.1007","volume":"401","author":[{"given":"Garry","family":"Milman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Schwope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene W.","family":"Schwilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deana L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,3]]},"reference":[{"issue":"9","key":"5066_CR1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addbeh.2008.04.009","volume":"33","author":"DM Ledgerwood","year":"2008","unstructured":"Ledgerwood DM, Goldberger BA, Risk NK, Lewis CE, Price RK (2008) Comparison between self-report and hair analysis of illicit drug use in a community sample of middle-aged men. Addict Behav 33(9):1131\u20131139","journal-title":"Addict Behav"},{"issue":"2\u20133","key":"5066_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.forsciint.2004.07.024","volume":"156","author":"F Musshoff","year":"2006","unstructured":"Musshoff F, Driever F, Lachenmeier K, Lachenmeier DW, Banger M, Madea B (2006) Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests. Forensic Sci Int 156(2\u20133):118\u2013123","journal-title":"Forensic Sci Int"},{"key":"5066_CR3","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/clinchem\/48.9.1486","volume":"48","author":"I Kim","year":"2002","unstructured":"Kim I, Barnes AJ, Oyler JM, Schepers R, Joseph RE Jr, Cone EJ, Lafko D, Moolchan ET, Huestis MA (2002) Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem 48:1486\u20131496","journal-title":"Clin Chem"},{"issue":"2\u20133","key":"5066_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2005.02.028","volume":"150","author":"DJ Crouch","year":"2005","unstructured":"Crouch DJ (2005) Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci Int 150(2\u20133):165\u2013173","journal-title":"Forensic Sci Int"},{"key":"5066_CR5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s004140050287","volume":"113","author":"N Samyn","year":"2000","unstructured":"Samyn N, van Haeren C (2000) On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int J Leg Med 113:150\u2013154","journal-title":"Int J Leg Med"},{"issue":"2","key":"5066_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/154411130201300209","volume":"13","author":"E Kaufman","year":"2002","unstructured":"Kaufman E, Lamster IB (2002) The diagnostic applications of saliva\u2014a review. Crit Rev Oral Biol Med 13(2):197\u2013212","journal-title":"Crit Rev Oral Biol Med"},{"issue":"11","key":"5066_CR7","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1373\/clinchem.2008.108670","volume":"55","author":"WM Bosker","year":"2009","unstructured":"Bosker WM, Huestis MA (2009) Oral fluid testing for drugs of abuse. Clin Chem 55(11):1910\u20131931","journal-title":"Clin Chem"},{"issue":"7","key":"5066_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jat\/30.7.413","volume":"30","author":"C Moore","year":"2006","unstructured":"Moore C, Ross W, Coulter C, Adams L, Rana S, Vincent M, Soares J (2006) Detection of the marijuana metabolite 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays. J Anal Toxicol 30(7):413\u2013418","journal-title":"J Anal Toxicol"},{"issue":"4","key":"5066_CR9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jat\/30.4.274","volume":"30","author":"GF Kauert","year":"2006","unstructured":"Kauert GF, Iwersen-Bergmann S, Toennes SW (2006) Assay of delta9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device. J Anal Toxicol 30(4):274\u2013277","journal-title":"J Anal Toxicol"},{"key":"5066_CR10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002130050848","volume":"141","author":"M Haney","year":"1999","unstructured":"Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW (1999) Abstinence symptoms following oral THC administration to humans. Psychopharmacol 141:385\u2013394","journal-title":"Psychopharmacol"},{"key":"5066_CR11","unstructured":"Food and Drug Administration (2004) MARINOL\u00ae (Dronabinol) Capsules. 500012 Rev Sep 2004 ed"},{"key":"5066_CR12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chroma.2009.12.053","volume":"1217","author":"G Milman","year":"2010","unstructured":"Milman G, Barnes AJ, Lowe RH, Huestis MA (2010) Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A 1217:1513\u20131521","journal-title":"J Chromatogr A"},{"issue":"3","key":"5066_CR13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/moe.2001.116814","volume":"92","author":"N Enberg","year":"2001","unstructured":"Enberg N, Alho H, Loimaranta V, Lenander-Lumikari M (2001) Saliva flow rate, amylase activity, and protein and electrolyte concentrations in saliva after acute alcohol consumption. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92(3):292\u2013298","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"5066_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5005\/jcdp-9-3-72","volume":"9","author":"PDV Almeida de","year":"2008","unstructured":"de Almeida PDV, Gr\u00e9gio AMT, Machado M\u00c2N, de Lima AAS, Azevedo LR (2008) Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 9(3):72\u201380","journal-title":"J Contemp Dent Pract"},{"key":"5066_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00007691-200204000-00006","volume":"24","author":"P Kintz","year":"2002","unstructured":"Kintz P, Samyn N (2002) Use of alternative specimens: drugs of abuse in saliva and doping agents in hair. Ther Drug Monit 24:239\u2013246","journal-title":"Ther Drug Monit"},{"key":"5066_CR16","first-page":"1","volume":"1","author":"KM Hold","year":"1996","unstructured":"Hold KM, De Boer D, Zuidema J, Maes RAA (1996) Saliva as an analytical tool in toxicology. Int J Drug Test 1:1\u201331","journal-title":"Int J Drug Test"},{"issue":"2","key":"5066_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/FTD.0b013e3181685088","volume":"30","author":"P Lillsunde","year":"2008","unstructured":"Lillsunde P (2008) Analytical techniques for drug detection in oral fluid. Ther Drug Monit 30(2):181\u2013187","journal-title":"Ther Drug Monit"},{"issue":"2\u20133","key":"5066_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.forsciint.2004.11.026","volume":"150","author":"H Teixeira","year":"2005","unstructured":"Teixeira H, Proenca P, Verstraete A, Corte-Real F, Vieira DN (2005) Analysis of delta-9-tetrahydrocannabinol in oral fluid samples using solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. Forensic Sci Int 150(2\u20133):205\u2013211","journal-title":"Forensic Sci Int"},{"issue":"8","key":"5066_CR19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1373\/clinchem.2009.141853","volume":"56","author":"G Milman","year":"2010","unstructured":"Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA (2010) Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem 56(8):1261\u20131269","journal-title":"Clin Chem"},{"issue":"5","key":"5066_CR20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jat\/31.5.288","volume":"31","author":"GF Kauert","year":"2007","unstructured":"Kauert GF, Ramaekers JG, Schneider E, Moeller MR, Toennes SW (2007) Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid. J Anal Toxicol 31(5):288\u2013293","journal-title":"J Anal Toxicol"},{"issue":"5","key":"5066_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jat\/25.5.289","volume":"25","author":"RS Niedbala","year":"2001","unstructured":"Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, Robb J, Cone EJ (2001) Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol 25(5):289\u2013303","journal-title":"J Anal Toxicol"},{"issue":"71","key":"5066_CR22","first-page":"19673","volume":"69","author":"DHHS","year":"2004","unstructured":"DHHS (2004) Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Fed Regist 69(71):19673\u201319732","journal-title":"Fed Regist"},{"issue":"1","key":"5066_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.fsisup.2009.08.001","volume":"1","author":"K Pil","year":"2009","unstructured":"Pil K, Raes E, Verstraete AG (2009) The toxicological challenges in the European research project DRUID. Forensic Sci Int Suppl Ser 1(1):29\u201332","journal-title":"Forensic Sci Int Suppl Ser"},{"key":"5066_CR24","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1111\/j.1360-0443.2009.02705.x","volume":"104","author":"E Karschner","year":"2009","unstructured":"Karschner E, Schwilke E, Lowe R, Darwin W, Pope H Jr, Herning R, Cadet J, Huestis M (2009) Do delta 9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction 104:2041\u20132048","journal-title":"Addiction"},{"issue":"8","key":"5066_CR25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jat\/33.8.469","volume":"33","author":"E Karschner","year":"2009","unstructured":"Karschner E, Schwilke E, Lowe R, Darwin WD, Herning R, Cadet J, Huestis M (2009) Implications of plasma delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. J Anal Toxicol 33(8):469\u2013477","journal-title":"J Anal Toxicol"},{"key":"5066_CR26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/clpt.1983.179","volume":"34","author":"ME Wall","year":"1983","unstructured":"Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M (1983) Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 34:352\u2013363","journal-title":"Clin Pharmacol Ther"},{"issue":"1\u20132","key":"5066_CR27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jchromb.2007.02.016","volume":"852","author":"C Moore","year":"2007","unstructured":"Moore C, Rana S, Coulter C (2007) Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid. J Chromatogr B Anal Technol Biomed Life Sci 852(1\u20132):459\u2013464","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-011-5066-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-011-5066-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-011-5066-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T20:29:52Z","timestamp":1592598592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-011-5066-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["5066"],"URL":"https:\/\/doi.org\/10.1007\/s00216-011-5066-4","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,3]]}}}